These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P. Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235 [No Abstract] [Full Text] [Related]
5. Clinical use of FK 506 in liver transplantation. Klintmalm GB. Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484 [Abstract] [Full Text] [Related]
9. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Sher LS, Cosenza CA, Petrovic LM, Rojter S, Hoffman A, Lopez RR, Meehan M, Pan SH, Vierling J, Makowka L. Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212 [No Abstract] [Full Text] [Related]
10. The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A. Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P. Transplant Proc; 1995 Feb; 27(1):1117-20. PubMed ID: 7533359 [No Abstract] [Full Text] [Related]
11. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. Lewis WD, Jenkins RL, Burke PA, Winn KM, Shaffer D, Lopez R, Monaco AP. Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336 [No Abstract] [Full Text] [Related]
12. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. Bismuth H. Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415 [No Abstract] [Full Text] [Related]
13. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P. Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635 [Abstract] [Full Text] [Related]
17. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R. Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762 [Abstract] [Full Text] [Related]
18. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection. Jain A. Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248 [No Abstract] [Full Text] [Related]
19. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. Mühlbacher F, European Liver Transplantation Tacrolimus vs Cyclosporin Microemulsion Study Group. Transplant Proc; 2001 Oct; 33(1-2):1339-40. PubMed ID: 11267317 [No Abstract] [Full Text] [Related]